PHILADELPHIA (GenomeWeb) – At the American Association for Clinical Chemistry annual meeting here today, BioRad Laboratories announced that it has received 510(k)clearance from the US Food and Drug Administration for a multi-analyte quality control designed to monitor the performance of in vitro nucleic acid tests for viral load assays used in the diagnosis of human immunodeficiency type 1, hepatitis B, and hepatitis C viruses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.